20
Participants
Start Date
June 1, 2019
Primary Completion Date
December 15, 2023
Study Completion Date
December 30, 2023
CD19-UCART
A conditioning therapy with cyclophosphamide and fludarabine will be conducted before CD19-UCART injection. VP16 can be added to the conditioning therapy.
First Affliated Hospital of Zhejiang University, Hangzhou
First Affliated Hospital of Zhengzhou University, Zhengzhou
Lead Sponsor
The First Affiliated Hospital of Zhengzhou University
OTHER
First Affiliated Hospital of Zhejiang University
OTHER
Second Xiangya Hospital of Central South University
OTHER
Bioray Laboratories
INDUSTRY